Fiber lowers cholesterol

Gel-forming soluble fibre lowers LDL cholesterol in randomized trials, by a few to about 13 mg/dL depending on the fibre and the analysis. The largest pooled analysis covers soluble fibre supplements of all kinds: across the 165 of its 181 trials that measured LDL, in about 12,800 adults, LDL was about 8 mg/dL (0.21 mmol/L) lower than in control groups. For psyllium alone, 41 trials in 2,049 adults found LDL about 8.5 mg/dL (0.22 mmol/L) lower, and an earlier analysis of 28 trials put it at about 13 mg/dL (0.33 mmol/L) at around 10 g of psyllium a day. Fibre in general does less: a Cochrane review of 23 trials across many fibre types found LDL about 5 mg/dL (0.14 mmol/L) lower.

The trials have three limits. First, they measured a blood marker over weeks to months, a year at the longest, and none of the pooled analyses reports heart attacks, strokes or deaths. Second, the effect belongs to viscous soluble fibres that form a gel, such as psyllium, oat fibre and pectin; the trials say little about insoluble fibre such as wheat bran. Third, the size of the effect is uncertain: results varied widely from trial to trial, and the largest analysis found signs that trials with favourable results were more likely to be published, so its authors rated their confidence in the LDL figure as very low. The two largest analyses cover adults only: people with raised cholesterol, type 2 diabetes or excess weight, and healthy volunteers. In the largest analysis the drop was bigger in people who started with raised cholesterol, about 18 mg/dL, though that estimate ranges from 5 to 31. In three trials of people already taking a statin, adding psyllium lowered LDL further, and in those trials psyllium was taken alongside the statin, not instead of it.

On dose, more soluble fibre went with a larger drop. In the largest analysis, each extra 5 g a day went with LDL about 5.6 mg/dL (0.14 mmol/L) lower, and the modelled drop reached about 11 mg/dL (0.28 mmol/L) at 10 g a day. An older analysis of 67 controlled trials found about 2 mg/dL (0.057 mmol/L) per gram in the 2 to 10 g a day range, with oat, psyllium and pectin fibre doing about the same per gram. Its authors gave a practical example: 3 g of oat soluble fibre, roughly three bowls of oatmeal, lowered LDL by about 5 mg/dL. Within psyllium alone the picture is flatter: the 28-trial analysis found no clear dose-response between 2.4 and 20.4 g a day, the 41-trial analysis found no significant trend with dose, and results varied widely from trial to trial.

Most trials gave isolated fibre as a powder, capsule or enriched cereal. The Cochrane review found no clear difference between fibre supplements and advice to eat more fibre-rich food, though too few trials sat in each group to tell. The World Health Organization's 2023 guideline recommends that adults get at least 25 g a day of naturally occurring fibre from whole grains, vegetables, fruits and pulses, to lower the risk of cardiovascular and other chronic diseases. That guidance concerns fibre in food, not supplements, and sets no cholesterol target.

Much of the psyllium research involves the company that makes Metamucil. The trial that measured how psyllium works was funded by Procter and Gamble with NIH support, and the analysis of psyllium alongside statins was written largely by Procter and Gamble employees who held the data. The independently funded reviews, the 181-trial soluble fibre analysis, the 2025 psyllium analysis and the Cochrane review, point the same way.

Psyllium is sold in the US as an over-the-counter laxative, and its label carries warnings that apply whatever the reason for taking it. Taken without enough fluid it can swell and block the throat or esophagus, and it is labelled not for people who have difficulty swallowing. It can cause allergic reactions in people sensitive to psyllium. The label directs taking it at least 2 hours before or after other medicines, because it can change how they work, and advises asking a health professional before use in pregnancy or while breastfeeding; the NIH lactation database notes psyllium is not absorbed and cannot enter breast milk. In the trials, side effects were mostly mild bloating and gas. The trials did not test psyllium as a replacement for cholesterol medication.